Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...

Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

Science Corporation says its retinal implant restored central vision in patients who were legally blind in a clinical trial.

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.

Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal implant in patients with central visual field loss due to geographic atrophy. The ...

Retinal implants are devices that restore vision by replacing damaged photoreceptors and transmitting electrical signals to normal nerve cells in the retina, enabling the signals to reach the ...

Science Corporation has acquired the IP and related assets for the PRIMA retinal implant. Combination Of Pixium’s Technology With The Science Eye Accelerates Opportunities For Vision Restoration “We ...

Retinal implants have recently gained attention as a potential treatment for RP-induced color blindness.

Retinal implants are designed to reverse vision loss from diseases like macular degeneration and retinitis pigmentosa by replacing the damaged light sensors in the eye with artificial ones.

This technology has the potential for new treatments of a wide range of conditions, from paralysis, to blindness, spinal cord injuries, strokes, or other disorders.